Skip to main content
. 2022 Apr 28;12(5):399. doi: 10.3390/metabo12050399

Figure 6.

Figure 6

Gene-set enrichment analysis with the significant differentially expressed proteins after 6- month treatment with denosumab. Blue bars to the right are showing upregulating effects to the specific pathway. Light blue is not significant (FDR > 0.05), whereas dark blue is significant (FDR < 0.05).